A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
מצבים רפואיים
Metastatic Castration-Resistant Prostate Cancer
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
Western Regional Medical Center - City of Hope Phoenix Goodyear, Goodyear, Arizona, United States
HonorHealth Research Institute, Scottsdale, Arizona, United States
The University of Arizona Cancer Center - North Campus, Tucson, Arizona, United States
VA Greater Los Angeles Healthcare System, Los Angeles, California, United States
UCLA Clark Urology Center, Los Angeles, California, United States
University of California San Francisco, San Francisco, California, United States
New Haven Hospital - Yale Cancer Center, New Haven, Connecticut, United States
Bioresearch Partner - Aventura, Aventura, Florida, United States
Bioresearch Partner - Hialeah, Hialeah, Florida, United States
Winship Cancer Institute, Emory University, Atlanta, Georgia, United States
East Jefferson General Hospital Metairie, New Orleans, Louisiana, United States
New Mexico Oncology Hematology Consultants, Ltd., Albuquerque, New Mexico, United States
Duke University Medical Center - Duke Cancer Center, Durham, North Carolina, United States
University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States
Carolina Urologic Research Center, Myrtle Beach, South Carolina, United States
University of Texas Southwestern Medical Center, Dallas, Texas, United States
Oncology Consultants, Houston, Texas, United States
University of Virginia Comprehensive Cancer Center, Charlottesville, Virginia, United States
Contact: Study coordinator (Clinical Trials Navigator) · uvacancertrials@hscmail.mcc.virginia.edu · 434-982-0539Fred Hutchinson Cancer Center, Seattle, Washington, United States
University of Washington Medical Center, Seattle, Washington, United States